Metformin placebo
Sponsors
Takeda, Boehringer Ingelheim, University Hospital, Gentofte, Copenhagen, Centro Universitario de Ciencias de la Salud, Mexico, EMS
Conditions
Diabetes MellitusDiabetes Mellitus, Type 2Metabolic SyndromeType 2 Diabetes Mellitus
Phase 3
Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 Diabetes
CompletedNCT01023581
Start: 2009-11-30End: 2011-06-30Updated: 2013-03-26
Efficacy and Safety of Alogliptin and Metformin Fixed-Dose Combination in Participants With Type 2 Diabetes
CompletedNCT01890122
Start: 2013-09-30End: 2015-10-31Updated: 2016-11-28
Combination of Metformin/Inulin vs Inulin on Adiponectin in Metabolic Syndrome
CompletedNCT02773927
Start: 2013-01-31End: 2015-06-30Updated: 2016-05-18
Combination of Metformine/Inulin Versus Metformin on Prostate Benign Hyperplasia in Metabolic Syndrome
CompletedNCT02778776
Start: 2013-01-31End: 2015-06-30Updated: 2016-05-20
Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus
RecruitingNCT04670666
Start: 2024-11-18End: 2027-06-30Target: 270Updated: 2025-12-08
Phase 4
Linagliptin in Combination With Metformin in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control
CompletedNCT01438814
Start: 2011-11-30End: 2013-03-31Updated: 2014-11-25
Linagliptin and Metformin Versus Linagliptin in Newly Diagnosed, Untreated Type 2 Diabetes
CompletedNCT01512979
Start: 2012-01-31End: 2013-04-30Updated: 2014-05-20